Sarepta Therapeutics, Inc. (SRPT)
21.03
+0.17
(+0.82%)
USD |
NASDAQ |
Aug 31, 16:00
20.80
-0.23
(-1.09%)
Pre-Market: 09:16
Sarepta Therapeutics Free Cash Flow : 58.34M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.34M |
| March 31, 2026 | 91.18M |
| December 31, 2025 | -332.39M |
| September 30, 2025 | -401.63M |
| June 30, 2025 | -453.97M |
| March 31, 2025 | -697.55M |
| December 31, 2024 | -352.74M |
| September 30, 2024 | -480.40M |
| June 30, 2024 | -528.06M |
| March 31, 2024 | -653.98M |
| December 31, 2023 | -588.34M |
| September 30, 2023 | -615.00M |
| June 30, 2023 | -532.58M |
| March 31, 2023 | -468.32M |
| December 31, 2022 | -356.17M |
| September 30, 2022 | -287.35M |
| June 30, 2022 | -347.72M |
| March 31, 2022 | -386.87M |
| December 31, 2021 | -481.66M |
| September 30, 2021 | -656.78M |
| June 30, 2021 | -786.69M |
| March 31, 2021 | -798.43M |
| December 31, 2020 | 21.76M |
| September 30, 2020 | 41.99M |
| June 30, 2020 | 228.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 258.51M |
| December 31, 2019 | -523.51M |
| September 30, 2019 | -480.27M |
| June 30, 2019 | -537.30M |
| March 31, 2019 | -567.85M |
| December 31, 2018 | -453.00M |
| September 30, 2018 | -345.41M |
| June 30, 2018 | -276.58M |
| March 31, 2018 | -238.12M |
| December 31, 2017 | -253.21M |
| September 30, 2017 | -302.21M |
| June 30, 2017 | -298.33M |
| March 31, 2017 | -254.02M |
| December 31, 2016 | -252.69M |
| September 30, 2016 | -200.91M |
| June 30, 2016 | -186.94M |
| March 31, 2016 | -172.29M |
| December 31, 2015 | -154.30M |
| September 30, 2015 | -150.40M |
| June 30, 2015 | -150.81M |
| March 31, 2015 | -165.75M |
| December 31, 2014 | -155.36M |
| September 30, 2014 | -145.01M |
| June 30, 2014 | -118.35M |
| March 31, 2014 | -86.89M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Moderna, Inc. | -1.244B |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| ImmunityBio, Inc. | -288.51M |
| X4 Pharmaceuticals, Inc. | -88.74M |
| MapLight Therapeutics, Inc. | -175.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 197.07M |
| Cash from Investing (Quarterly) | -93.37M |
| Free Cash Flow Per Share (Quarterly) | 1.864 |
| Free Cash Flow to Equity (Quarterly) | 187.33M |
| Free Cash Flow to Firm (Quarterly) | 256.65M |
| Free Cash Flow Yield | 2.57% |